Similar Items: Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer
- Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
- Drug‐Induced Lung Injury Masking Lung Adenocarcinoma
- A Concise Review of the Approved MET TKIs (Savolitinib, Gumarontinib, Vebreltinib, Tepotinib, Capmatinib) in China for MET Exon 14 Splice Site Mutated (METex14+) NSCLC Circa 2025
- HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib – A Case Report
- Diagnosis and management of interstitial lung disease
- Acute lung injury and the role of histones